MedTrace Logo

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2023-08-18

No results posted yet for this study

Summary

The main purpose of this study is:

• to evaluate the efficacy and safety of MMH-407 in the treatment of influenza in outpatient adults.

Conditions

Interventions

DRUG

MMH-407

MMH-407: For oral use.

DRUG

Placebo

Placebo: For oral use.

Sponsors & Collaborators

  • Materia Medica Holding

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-12
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04250311 on ClinicalTrials.gov